Literature DB >> 10433948

Onset and dynamics of osteosclerosis in mice induced by Reilly-Finkel-Biskis (RFB) murine leukemia virus. Increase in bone mass precedes lymphomagenesis.

J Schmidt1, K Lumniczky, B D Tzschaschel, H L Guenther, A Luz, S Riemann, W Gimbel, V Erfle, R G Erben.   

Abstract

Newborn NMRI strain mice were infected with Reilly-Finkel-Biskis (RFB) murine leukemia virus (MuLV), a murine leukemia virus that has been shown to induce lymphomas, osteosclerosis, and osteomas in susceptible strains of mice. Bone histomorphometry of the distal femoral metaphyses at 3-month intervals showed osteosclerosis 3 (100%), 6 (100%), and 9 (93%) months after infection. This was represented by significantly augmented cancellous bone mass and accompanied by distinct changes in bone architecture. High numbers of provirus copies were detected at 2-4 weeks in femora, humeri, and calvaria, and viral protein was highly expressed in trabecular and cortical bone cells, particularly in osteocytes. Infected mice showed enhanced bone formation and smaller numbers of osteoclasts relative to sex- and age-matched controls. Osteoclastic differentiation was significantly reduced in cocultures of spleen or bone marrow cells with RFB MuLV-infected osteoclastogenic, osteoblast-like cells. However, RFB MuLV did not impair the activity of mature osteoclasts. In infected mice lymphomas were only observed at 6 (22%) and 9 months (40%) of age. At 3 months, IgG gene and TCR-beta gene rearrangements were not detectable, and new proviruses showed a heterogeneous integration pattern, indicating the absence of lymphoma in early osteosclerotic mice. In contrast, lymphomas, which developed in 8- to 9-month-old infected mice, showed IgG rearrangements indicating development of B-cell lymphomas, together with mono- or oligoclonal expansion of distinct patterns of proviral integrations. These results indicate that RFB MuLV-induced osteosclerosis develops within 3 months after infection and precedes lymphomagenesis. It may therefore be considered an independent skeletal lesion in MuLV-infected mice.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10433948      PMCID: PMC1866854          DOI: 10.1016/S0002-9440(10)65151-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  51 in total

1.  Retrovirus-induced osteopetrosis in mice. Effects of viral infection on osteogenic differentiation in skeletoblast cell cultures.

Authors:  J Schmidt; M Casser-Bette; A B Murray; A Luz; V Erfle
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

2.  SL3-3 enhancer factor 1 transcriptional activators are required for tumor formation by SL3-3 murine leukemia virus.

Authors:  B Hallberg; J Schmidt; A Luz; F S Pedersen; T Grundström
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Charlotte Friend Memorial Lecture: murine leukemia virus (MuLV) tumorigenesis.

Authors:  J W Hartley; S K Chattopadhyay; H C Morse; T N Fredrickson
Journal:  Leukemia       Date:  1997-04       Impact factor: 11.528

Review 4.  Friend virus-induced erythroleukemia and the multistage nature of cancer.

Authors:  Y Ben-David; A Bernstein
Journal:  Cell       Date:  1991-09-06       Impact factor: 41.582

5.  Effects of leukemogenic retroviruses on condylar cartilage in vitro: an ultrastructural study.

Authors:  E Livne; J Schmidt; E I Closs; M Silbermann; V Erfle
Journal:  Calcif Tissue Int       Date:  1989-01       Impact factor: 4.333

6.  Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.

Authors:  A M Parfitt; M K Drezner; F H Glorieux; J A Kanis; H Malluche; P J Meunier; S M Ott; R R Recker
Journal:  J Bone Miner Res       Date:  1987-12       Impact factor: 6.741

7.  Histomorphometric analysis of the rat proximal tibial metaphysis by "linear scanning".

Authors:  R G Erben; B Kohn; W A Rambeck; H Zucker
Journal:  Scanning Microsc       Date:  1990-09

8.  Pathogenicity of BALB/c-derived N-tropic murine leukemia viruses.

Authors:  L Pedersen; P G Strauss; J Schmidt; A Luz; V Erfle; P Jørgensen; N O Kjeldgaard; F S Pedersen
Journal:  Virology       Date:  1990-12       Impact factor: 3.616

9.  Endogenous murine leukemia viruses: frequency of radiation-activation and novel pathogenic effects of viral isolates.

Authors:  J Schmidt; A Luz; V Erfle
Journal:  Leuk Res       Date:  1988       Impact factor: 3.156

10.  Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice.

Authors:  P Soriano; C Montgomery; R Geske; A Bradley
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

View more
  4 in total

1.  Increased induction of osteopetrosis, but unaltered lymphomagenicity, by murine leukemia virus SL3-3 after mutation of a nuclear factor 1 site in the enhancer.

Authors:  S Ethelberg; B D Tzschaschel; A Luz; S J Diaz-Cano; F S Pedersen; J Schmidt
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  RANKL-RANK signaling regulates expression of xenotropic and polytropic virus receptor (XPR1) in osteoclasts.

Authors:  Parul Sharma; Somying Patntirapong; Steven Hann; Peter V Hauschka
Journal:  Biochem Biophys Res Commun       Date:  2010-07-13       Impact factor: 3.575

3.  Loss of MicroRNA targets in the 3' untranslated region as a mechanism of retroviral insertional activation of growth factor independence 1.

Authors:  Magdalena Julia Dabrowska; Karen Dybkaer; Hans Erik Johnsen; Bruce Wang; Matthias Wabl; Finn Skou Pedersen
Journal:  J Virol       Date:  2009-05-27       Impact factor: 5.103

4.  Murine models of B-cell lymphomas: promising tools for designing cancer therapies.

Authors:  Sabrina Donnou; Claire Galand; Valérie Touitou; Catherine Sautès-Fridman; Zsuzsanna Fabry; Sylvain Fisson
Journal:  Adv Hematol       Date:  2012-02-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.